Go MF protein dimerization activity |
10 |
39 |
171 |
10 134 |
AMBP/APOA2/APOA4/APOB/APOE/CST3/EGFR/ERBB2/IL12B/VWF |
0.000999001 |
0.0834165834 |
Go MF protein homodimerization activity |
6 |
43 |
114 |
10 191 |
AMBP/APOA2/APOA4/APOE/CST3/VWF |
0.000999001 |
0.0834165834 |
Go BP protein secretion |
5 |
44 |
27 |
10 278 |
ANG/APOA1/APOA2/INS/PPY |
0.002997003 |
0.1251248751 |
Go MF protein heterodimerization activity |
6 |
43 |
71 |
10 234 |
APOA2/APOB/APOE/EGFR/ERBB2/IL12B |
0.002997003 |
0.1251248751 |
Go BP lipid homeostasis |
4 |
45 |
12 |
10,293 |
APOA1/APOA2/APOA4/APOE |
0.004995005 |
0.1429998573 |
Reactome chylomicron mediated lipid transport |
5 |
44 |
12 |
10,293 |
APOA1/APOA2/APOA4/APOB/APOE |
0.005994006 |
0.1429998573 |
Go BP regulation of hydrolase activity |
3 |
46 |
72 |
10,233 |
ANG/APOA2/EGFR |
0.005994006 |
0.1429998573 |
Go BP establishment of protein localization |
6 |
43 |
178 |
10,127 |
ANG/APOA1/APOA2/INS/EGFR/PPY |
0.006993007 |
0.145979021 |
Reactome lipoprotein metabolism |
5 |
44 |
22 |
10,283 |
APOA1/APOA2/APOA4/APOB/APOE |
0.008991009 |
0.1668331668 |
Go MF phospholipid binding |
3 |
46 |
38 |
10,267 |
APOA1/APOA4/APOE |
0.011988012 |
0.1787498216 |
Go BP regulation of protein secretion |
4 |
45 |
18 |
10,287 |
ANG/APOA1/APOA2/INS |
0.012987013 |
0.1787498216 |
Go BP regulation of secretion |
4 |
45 |
36 |
10,269 |
ANG/APOA1/APOA2/INS |
0.012987013 |
0.1787498216 |
Go BP lipoprotein metabolic process |
3 |
46 |
30 |
10,275 |
APOA1/APOA2/APOA4 |
0.013986014 |
0.1787498216 |
Go BP lipid transport |
4 |
45 |
24 |
10,281 |
APOA1/APOA2/APOA4/APOE |
0.014985015 |
0.1787498216 |
Go MF peptide binding |
2 |
47 |
80 |
10,225 |
ANG/MSLN |
0.021978022 |
0.2446886447 |
Go BP Secretion by cell |
5 |
44 |
109 |
10,196 |
ANG/APOA1/APOA2/INS/PPY |
0.035964036 |
0.2678111362 |
Go BP cytokine secretion |
3 |
46 |
15 |
10,290 |
APOA1/APOA2/INS |
0.036963037 |
0.2678111362 |
Biocarta ppara pathway |
4 |
45 |
54 |
10,251 |
APOA1/APOA2/INS/FABP1 |
0.037962038 |
0.2678111362 |
Go CC cytoplasmic membrane bound vesicle |
3 |
46 |
109 |
10,196 |
APOA1/EGFR/VWF |
0.037962038 |
0.2678111362 |
Go CC membrane bound vesicle |
3 |
46 |
111 |
10,194 |
APOA1/EGFR/VWF |
0.037962038 |
0.2678111362 |
Go BP phospholipase c activation |
2 |
47 |
9 |
10,296 |
ANG/EGFR |
0.038961039 |
0.2678111362 |
Go BP Positive regulation of hydrolase activity |
2 |
47 |
49 |
10,256 |
ANG/EGFR |
0.038961039 |
0.2678111362 |
Go BP G protein signaling coupled to IP3 second messenger/PLC activating |
2 |
47 |
39 |
10,266 |
ANG/EGFR |
0.040959041 |
0.2678111362 |
Go BP phosphoinositide mediated signaling |
2 |
47 |
42 |
10,263 |
ANG/EGFR |
0.040959041 |
0.2678111362 |
Go BP regulation of cytokine secretion |
3 |
46 |
13 |
10,292 |
APOA1/APOA2/INS |
0.041958042 |
0.2678111362 |
Go BP regulation of protein stability |
2 |
47 |
17 |
10,288 |
APOA1/APOA2 |
0.041958042 |
0.2678111362 |
Go BP lipid biosynthetic process |
3 |
46 |
94 |
10,211 |
ANG/APOA1/MIF |
0.044955045 |
0.2678111362 |
Go BP lipoprotein biosynthetic process |
2 |
47 |
24 |
10,281 |
APOA1/APOA2 |
0.047952048 |
0.2678111362 |
Go MF protein complex binding |
3 |
46 |
51 |
10,254 |
AMBP/INS/VWF |
0.048951049 |
0.2678111362 |
Go BP negative regulation of secretion |
2 |
47 |
11 |
10,294 |
APOA1/APOA2 |
0.04995005 |
0.2678111362 |
Go CC extracellular matrix part |
2 |
47 |
55 |
10,250 |
ANG/COL18A1 |
0.04995005 |
0.2678111362 |